BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 29, 2019
View Archived Issues
Metastasizing cells create their own hypoxia
Read More
For proinflammatory antibody, too much of a bad thing is a good thing
Read More
Phase III results for V-212 inactivated varicella zoster virus vaccine in patients with malignancies
Read More
Novo Nordisk initiates phase I study of NNC0385-0434 for hypercholesterolemia
Read More
Recruitment ongoing in first-in-human trial of GB-1275
Read More
Velabs Therapeutics and Chiome Bioscience enter into a screening cooperation
Read More
Discovery and preclinical identification of novel mutant EGFR allosteric inhibitor JBJ-04-125-02
Read More
Celgene identifies CELMoD compounds for treating relapsed and refractory multiple myeloma
Read More
Merck & Co. describes heme-displacing inhibitors of IDO-1 with enhanced target engagement
Read More
Alpine Androsciences presents new androgen receptor antagonists
Read More
Aptinyx discovers NMDA receptor modulators
Read More
New TYK2 inhibitors disclosed by Nimbus Lakshmi
Read More
Foshan Ionova Biotherapeutics, Shenzhen Ionova Life Science patent PTGER4 antagonists
Read More
Vanderbilt University presents new muscarinic M4 receptor antagonists
Read More
2,3,6-Trisubstituted pyridine-containing M4 PAM shows selectivity and preclinical efficacy
Read More
Discovery of pyridinylimidazoles as brain-penetrant dual kinase inhibitors
Read More
Spider silk and iron oxide nanoparticles show promise for theranostic cancer applications
Read More
Immunicum reports phase II data on ilixadencel with sunitinib in metastatic renal cell carcinoma
Read More
European Commission approves Tecentriq for TNBC
Read More
Acurx completes multiple-ascending-dose phase I study of ACX-362E for C. difficile infection
Read More
Phase III TULIP 2 trial of anifrolumab in SLE meets primary endpoint
Read More
Amyndas opens phase IIa study of AMY-101 in periodontal inflammation
Read More
